SUPER IMPEX
COPPER & BRASS ALLOYS, BRASS EXTRUDED RODS, SECTIONS, TUBES, WIRES & INGOTS COPPER & BRASS ALLOYS, BRASS EXTRUDED RODS, SECTIONS, TUBES, WIRES & INGOTS Copper Products
COPPER & BRASS ALLOYS, BRASS EXTRUDED RODS, SECTIONS, TUBES, WIRES & INGOTS COPPER & BRASS ALLOYS, BRASS EXTRUDED RODS, SECTIONS, TUBES, WIRES & INGOTS Copper Products
Oil Marketing Companies are facing substantial losses on petrol and diesel. Despite recent price increases, these companies are still losing money on every litre sold.…
Sebi has proposed a relaxation in the net distributable cash flow calculation for road sector InvITs. The regulator will allow debt-funded major maintenance expenses to…
Insurers will soon be able to undertake repo and government securities lending transactions. The insurance regulator is developing an operational framework for these activities. This…
MarketSmith India reveals its top stock recommendations for today, 2 June. Get expert insights into the best-performing stocks to guide your investment decisions.
Acquisitions have taken the shopping bills of the country’s 15 largest IT services companies to $5 billion since April last year, helping them to increase…
Market expert Raja Venkatraman shares his top stock picks for 2 June. Here’s his technical outlook and trade strategy.
All three trade for less than ₹100 a share, and at a lower price-to-earnings and price-to-book ratio than the indices to which they belong.
When Tata Sons invested again in Tata Digital this year, it was at a lower valuation. Tata's effort to build an everything-app through Tata Digital…
Nvidia is stepping up H-1B hiring even as rivals scale back. Federal filings reveal salaries for software engineers, AI researchers, product managers and directors, with…
More companies turned loss-making in Q4FY26 despite stronger revenue growth, as rising raw material costs exposed smaller businesses with limited pricing power. Analysts warn the…
Wockhardt's novel antibiotic, Zaynich, has received USFDA approval after a 12-year effort, sparking hopes for a turnaround after years of net losses. The drug, targeting…